Achievements in new drug clinical development

Department of Clinical Pharmacology and Therapeutics of Seoul National University college of Medicine and Hospital contributes to successful clinical development of new drugs through conducting clinical trials and consultation of clinical trials development.

  • 2015년

    SUGANON – Dong-A ST Co.,LtdOral Hypoglycemic Agent

  • 2012년

    ZEMIGLO - LG Life Sciences, LtdAntidiabetics

  • 2010년

    KANARB - Boryung Pharmaceutical Co., Ltd.Antihypertensive agents

  • 2022
    Envlo Tab.
    Daewoong Pharmaceutical Co., Ltd.
  • 2021
    Fexuclue Tab.
    Daewoong Pharmaceutical Co., Ltd.
  • 2018
    K-CAB Tab.
    HK inno.N Corporation
  • 2015
    SUGANON
    Dong-A ST Co.,Ltd
  • 2015
    Sivextro Injection
    Dong-A ST Co.,Ltd
  • 2013
    DUVIE Tablet
    Chong Kun Dang Pharmaceutical Corp.
  • 2012
    Gemigliptin Tablet
    LG Chem, Ltd
  • 2011
    PYRAMAX
    Shinpoong Pharm.co.,LTd
  • 2010
    Kanarb Tablet
    Boryung Pharmaceutical Co.,Ltd.
  • 2007
    MVIX TAB.
    SK Discovery Co.
  • 2005
    ZYDENA Tablet
    Dong-A ST Co.,Ltd
  • 2005
    REVANEX
    Yuhan Corporation
  • 2002
    Factive Tablet
    LG Chem, Ltd(주)
  • 2001
    Q-ROXIN TAB.
    JW Pharmaceutical
Research involved in SNUCPT